GB2278780B - Macrolide formulations - Google Patents
Macrolide formulationsInfo
- Publication number
- GB2278780B GB2278780B GB9410252A GB9410252A GB2278780B GB 2278780 B GB2278780 B GB 2278780B GB 9410252 A GB9410252 A GB 9410252A GB 9410252 A GB9410252 A GB 9410252A GB 2278780 B GB2278780 B GB 2278780B
- Authority
- GB
- United Kingdom
- Prior art keywords
- macrolide
- formulations
- macrolide formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9410252A GB2278780B (en) | 1993-05-27 | 1994-05-23 | Macrolide formulations |
GB9722958A GB2315216B (en) | 1993-10-05 | 1994-05-23 | Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310974A GB9310974D0 (en) | 1993-05-27 | 1993-05-27 | Organic compounds |
GB939320463A GB9320463D0 (en) | 1993-10-05 | 1993-10-05 | Organic compounds |
GB9410252A GB2278780B (en) | 1993-05-27 | 1994-05-23 | Macrolide formulations |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9410252D0 GB9410252D0 (en) | 1994-07-13 |
GB2278780A GB2278780A (en) | 1994-12-14 |
GB2278780B true GB2278780B (en) | 1998-10-14 |
Family
ID=27266701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9410252A Expired - Fee Related GB2278780B (en) | 1993-05-27 | 1994-05-23 | Macrolide formulations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2278780B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1009856A5 (en) | 1995-07-14 | 1997-10-07 | Sandoz Sa | Pharmaceutical composition in the form of a solid release including macrolide and a vehicle. |
GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
ATE340586T1 (en) | 1996-07-30 | 2006-10-15 | Novartis Pharma Gmbh | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION AND AUTOIMMUNE OR INFLAMMATORY CONDITIONS |
DE19635553A1 (en) | 1996-09-02 | 1998-03-05 | Henkel Kgaa | Emulsifier mixtures |
CA2230748C (en) * | 1997-03-14 | 2010-08-03 | American Home Products Corporation | Rapamycin formulations for oral administration |
GB2380674B (en) * | 1998-03-06 | 2003-05-28 | Novartis Ag | Emulsion preconcentrates containing cyclosporin or a macrolide |
ID25908A (en) * | 1998-03-06 | 2000-11-09 | Novartis Ag | EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES |
TW537894B (en) * | 1998-05-26 | 2003-06-21 | Novartis Ag | A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist |
US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
GB9912476D0 (en) | 1999-05-28 | 1999-07-28 | Novartis Ag | Organic compounds |
IL159729A0 (en) * | 2004-01-06 | 2004-06-20 | Doron I Friedman | Non-aqueous composition for oral delivery of insoluble bioactive agents |
KR101387456B1 (en) | 2005-02-09 | 2014-04-21 | 산텐 세이야꾸 가부시키가이샤 | Liquid formulations for treatment of diseases or conditions |
US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
EP2001438A2 (en) | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
DK2001466T3 (en) | 2006-03-23 | 2016-02-29 | Santen Pharmaceutical Co Ltd | LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB907430A (en) * | 1960-02-04 | 1962-10-03 | Abbott Lab | A method for the preparation of chemically stable liquid suspensions of erythromycinand the suspensions so prepared |
GB1322306A (en) * | 1971-04-15 | 1973-07-04 | Meiji Seika Co | Stabilized antibiotic preparation and manufacturing process therefor |
EP0041795A2 (en) * | 1980-06-02 | 1981-12-16 | Ayerst, Mckenna And Harrison Inc. | Injectable composition of rapamycin |
JPS61291520A (en) * | 1985-06-19 | 1986-12-22 | Daigo Eiyou Kagaku Kk | Fat emulsion of erythromycin |
EP0302370A1 (en) * | 1987-08-07 | 1989-02-08 | Abbott Laboratories | Erythromycin formulations for oral administration |
GB2222770A (en) * | 1988-09-16 | 1990-03-21 | Sandoz Ltd | Cyclosporin emulsion compositions |
EP0361928A2 (en) * | 1988-09-29 | 1990-04-04 | Shiseido Company Limited | Emulsified composition |
WO1990014094A1 (en) * | 1989-05-26 | 1990-11-29 | Abbott Laboratories | Injectable clarithromycin composition |
EP0483842A1 (en) * | 1990-11-02 | 1992-05-06 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing tricyclic compounds |
GB2257359A (en) * | 1991-06-27 | 1993-01-13 | Sandoz Ltd | Cyclosporin compositions for oral administration |
WO1993020833A1 (en) * | 1992-04-22 | 1993-10-28 | Sandoz Ltd. | Pharmaceutical composition containing cyclosporin derivative |
-
1994
- 1994-05-23 GB GB9410252A patent/GB2278780B/en not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB907430A (en) * | 1960-02-04 | 1962-10-03 | Abbott Lab | A method for the preparation of chemically stable liquid suspensions of erythromycinand the suspensions so prepared |
GB1322306A (en) * | 1971-04-15 | 1973-07-04 | Meiji Seika Co | Stabilized antibiotic preparation and manufacturing process therefor |
EP0041795A2 (en) * | 1980-06-02 | 1981-12-16 | Ayerst, Mckenna And Harrison Inc. | Injectable composition of rapamycin |
JPS61291520A (en) * | 1985-06-19 | 1986-12-22 | Daigo Eiyou Kagaku Kk | Fat emulsion of erythromycin |
EP0302370A1 (en) * | 1987-08-07 | 1989-02-08 | Abbott Laboratories | Erythromycin formulations for oral administration |
GB2222770A (en) * | 1988-09-16 | 1990-03-21 | Sandoz Ltd | Cyclosporin emulsion compositions |
EP0361928A2 (en) * | 1988-09-29 | 1990-04-04 | Shiseido Company Limited | Emulsified composition |
WO1990014094A1 (en) * | 1989-05-26 | 1990-11-29 | Abbott Laboratories | Injectable clarithromycin composition |
EP0483842A1 (en) * | 1990-11-02 | 1992-05-06 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing tricyclic compounds |
GB2257359A (en) * | 1991-06-27 | 1993-01-13 | Sandoz Ltd | Cyclosporin compositions for oral administration |
WO1993020833A1 (en) * | 1992-04-22 | 1993-10-28 | Sandoz Ltd. | Pharmaceutical composition containing cyclosporin derivative |
Non-Patent Citations (1)
Title |
---|
Chem.Abs.106:162589 & JP 61291520 A * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
Also Published As
Publication number | Publication date |
---|---|
GB9410252D0 (en) | 1994-07-13 |
GB2278780A (en) | 1994-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1011278A1 (en) | Macrolide formulations | |
EP0634459A3 (en) | Formulations. | |
EP0721328A4 (en) | Camptothecin formulations | |
IL111004A0 (en) | Oral rapamycin formulations | |
IL111978A (en) | Dry-compressed paroxetine formulations | |
ZA942814B (en) | Agricultural formulations | |
ZA946195B (en) | Anthelmintic formulations | |
GB2278780B (en) | Macrolide formulations | |
GB9214390D0 (en) | Formulations | |
GB9303832D0 (en) | Speculum | |
GB9323399D0 (en) | Pharmaceutical formulations | |
GB9311030D0 (en) | Pharmaceutical formulations | |
GB9509291D0 (en) | Formulations | |
GB2327611B (en) | Macrolide compositions | |
GB9306144D0 (en) | Formulations | |
GB9308622D0 (en) | Formulations | |
GB9205738D0 (en) | Formulations | |
GB9202474D0 (en) | Formulations | |
GB9213271D0 (en) | Formulations | |
GB9205739D0 (en) | Formulations | |
GB9224539D0 (en) | Formulations | |
GB9608869D0 (en) | Antibiotic formulations | |
GB9508144D0 (en) | Formulations | |
GB9510349D0 (en) | Formulations | |
GB9509941D0 (en) | Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20120523 |